{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:42:40Z","timestamp":1792798960684,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.humimm.2024.111210","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T05:51:53Z","timestamp":1733982713000},"page":"111210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic implication of CD47 and CTLA-4 expressions in endometrial carcinoma"],"prefix":"10.1016","volume":"86","author":[{"given":"Mona Mostafa","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Abdalsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Barakat","family":"Waley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda F.","family":"Ebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha Mahmoud Hamed","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Nabil","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0005","article-title":"Changes in uterine cancer incidence rates in Egypt","volume":"2018","author":"Alshahrani","year":"2018","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.humimm.2024.111210_bb0010","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.humimm.2024.111210_bb0015","series-title":"WHO Classification of Female Genital Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"issue":"6","key":"10.1016\/j.humimm.2024.111210_bb0020","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e78","article-title":"Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study","volume":"35","author":"Chang","year":"2024","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204211","article-title":"Generation and integrated analysis of advanced patient-derived Orthoxenograft models (PDOX) for the rational assessment of targeted therapies in endometrial Cancer","volume":"10","author":"Devis-Jauregui","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.humimm.2024.111210_bb0030","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4103\/ijpm.ijpm_223_21","article-title":"Significance of CD47 expression in endometrial carcinoma","volume":"65","author":"Sahin","year":"2022","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.humimm.2024.111210_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","article-title":"The CD47\u2013SIRP\u03b1 pathway in cancer immune evasion and potential therapeutic implications","volume":"24","author":"Chao","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2024.111210_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00384-012-1541-4","article-title":"Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer","volume":"28","author":"Lascorz","year":"2013","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.humimm.2024.111210_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-019-00469-5","article-title":"CD47: role in the immune system and application to cancer therapy","volume":"43","author":"Hayat","year":"2020","journal-title":"Cell. Oncol."},{"issue":"605","key":"10.1016\/j.humimm.2024.111210_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg8693","article-title":"Dual targeting of CTLA-4 and CD47 on Treg cells promotes immunity against solid tumors","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2024.111210_bb0055","doi-asserted-by":"crossref","first-page":"9803","DOI":"10.1038\/s41598-022-13764-3","article-title":"Role of CD47 in tumor immunity: a potential target for combination therapy","volume":"12","author":"Huang","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-023-00418-4","article-title":"Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition","volume":"7","author":"Al-Sudani","year":"2023","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12957-024-03308-6","article-title":"CD47\u2014a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features","volume":"22","author":"Luo","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.humimm.2024.111210_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7188972","article-title":"Expression of CD47 in endometrial Cancer and its Clinicopathological significance","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2024.111210_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/15321819.2021.1981377","article-title":"Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4+\/CD8+ tumor infiltrating lymphocytes (TILs) ratio","volume":"43","author":"Khalifa","year":"2022","journal-title":"J. Immunoass. Immunochem."},{"issue":"2","key":"10.1016\/j.humimm.2024.111210_bb0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijgo.14969","article-title":"Molecular subtypes of endometrial cancer: implications for adjuvant treatment strategies","volume":"164","author":"Yang","year":"2024","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"12","key":"10.1016\/j.humimm.2024.111210_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.humimm.2024.111210_bb0090","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/cam4.478","article-title":"CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer","volume":"4","author":"Yoshida","year":"2015","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.humimm.2024.111210_bb0095","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/cancers13061440","article-title":"CTLA-4 in regulatory T cells for Cancer immunotherapy","volume":"13","author":"Sobhani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2024.111210_bb0100","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fonc.2020.01525","article-title":"CD47 enhances cell viability and migration ability but inhibits apoptosis in endometrial carcinoma cells via the PI3K\/Akt\/mTOR signaling pathway","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.humimm.2024.111210_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/PGP.0000000000000809","article-title":"Clinicopathologic and prognostic significance of CD47 expression and tumor-associated macrophages in endometrial carcinoma","volume":"41","author":"Sercan","year":"2022","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.humimm.2024.111210_bb0110","series-title":"Robboy\u2019s Pathology of the Female Reproductive Tract","author":"Robboy","year":"2009"},{"key":"10.1016\/j.humimm.2024.111210_bb0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18173","article-title":"Replication study: the CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"6","author":"Horrigan","year":"2017","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.humimm.2024.111210_bb0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.canlet.2015.02.036","article-title":"Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma","volume":"360","author":"Xiao","year":"2015","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.humimm.2024.111210_bb0125","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1121629109","article-title":"Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma","volume":"109","author":"Edris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.humimm.2024.111210_bb0130","first-page":"3249","article-title":"High expression of CD47 in triple negative breast cancer is associated with epithelial-mesenchymal transition and poor prognosis","volume":"18","author":"Yuan","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.humimm.2024.111210_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","article-title":"Is CD47 an innate immune checkpoint for tumour evasion?","volume":"10","author":"Liu","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2024.111210_bb0140","first-page":"9075","article-title":"CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma","volume":"15","author":"Ye","year":"2018","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.humimm.2024.111210_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1652540","article-title":"Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients","volume":"8","author":"Chen","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.humimm.2024.111210_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6156757","article-title":"CD47 blockade inhibits tumor progression through promoting phagocytosis of tumor cells by M2 polarized macrophages in endometrial Cancer","volume":"2018","author":"Gu","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.humimm.2024.111210_bb0155","doi-asserted-by":"crossref","first-page":"39021","DOI":"10.18632\/oncotarget.16547","article-title":"CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.humimm.2024.111210_bb0160","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/cam4.2882","article-title":"Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer","volume":"9","author":"Arrieta","year":"2020","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.humimm.2024.111210_bb0165","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jog.15953","article-title":"Spatial distribution of tumor-resident macrophages as predictive biomarkers in endometrial cancer","volume":"50","author":"Matsukawa","year":"2024","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.humimm.2024.111210_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41419-023-06391-x","article-title":"Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy","volume":"15","author":"Babamohamadi","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.humimm.2024.111210_bb0175","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00262-015-1696-2","article-title":"Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis","volume":"64","author":"Yu","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"issue":"18","key":"10.1016\/j.humimm.2024.111210_bb0180","doi-asserted-by":"crossref","first-page":"26670","DOI":"10.18632\/oncotarget.8476","article-title":"Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0185","first-page":"15","article-title":"Mechanisms of immune response regulation in lung cancer","volume":"3","author":"Domagala-Kulawik","year":"2014","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2\u20133","key":"10.1016\/j.humimm.2024.111210_bb0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12307-019-00225-1","article-title":"Immunosuppressive tumor microenvironment status and histological grading of endometrial carcinoma","volume":"12","author":"Antomarchi","year":"2019","journal-title":"Cancer Microenviron."},{"issue":"2","key":"10.1016\/j.humimm.2024.111210_bb0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.humimm.2024.111210_bb0205","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.humimm.2024.111210_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152782","article-title":"The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix","volume":"216","author":"Karpathiou","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"9","key":"10.1016\/j.humimm.2024.111210_bb0215","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.21037\/tcr-21-561","article-title":"A pan-cancer study of PD-1 and CTLA-4 as therapeutic targets","volume":"10","author":"Cai","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"4","key":"10.1016\/j.humimm.2024.111210_bb0220","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.21155","article-title":"CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction","volume":"117","author":"Contardi","year":"2005","journal-title":"Int. J. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924004737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924004737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T21:11:56Z","timestamp":1740085916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924004737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0198885924004737"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111210","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic implication of CD47 and CTLA-4 expressions in endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111210"}}